CBD vs THC: The Plain-Language Comparison (2026)

Last updated: April 22, 2026 · By Steve Schultheis, Founder — Steve's Goods

CBD and THC are the two cannabinoids most hemp shoppers have heard of — and also the two that most shoppers confuse at the label. They come from the same plant family, interact with the same receptor system in the body, and often appear on the same Certificate of Analysis. But they are not interchangeable: one is intoxicating and one is not, one is age-gated at 21+ in hemp-derived form and one isn't, and one is capped per container under the new federal framework taking effect November 12, 2026. This guide covers everything you need to read a modern hemp label correctly.

Table of contents

• The short answer
• The chemistry
• Side-by-side comparison
• How they act in the body
• Legal status, Farm Bill and H.R. 5371
• Why products often combine them
• How to read a modern hemp label
• FAQ

The short answer

CBD is not intoxicating. It is the cannabinoid most associated with general, daytime-friendly hemp products. THC — specifically delta-9 THC — is the intoxicating cannabinoid. Hemp products can legally contain small amounts of delta-9 THC under the 2018 Farm Bill, and starting November 12, 2026, ingestible hemp products are capped at 0.4 mg of total THC per finished container under H.R. 5371. That's the headline. Everything below is the detail.

The chemistry

Both compounds come from the same precursor: cannabigerolic acid (CBGA), sometimes called "the mother cannabinoid." Inside the plant, enzymatic reactions convert CBGA into CBDA or THCA, which then decarboxylate — shed a carbon dioxide — into CBD and THC when exposed to heat. The two resulting molecules differ by the shape of a single carbon ring, but that tiny structural difference is what determines whether the molecule fits neatly into the brain's CB1 receptor (THC) or interacts with the endocannabinoid system in a more indirect way (CBD).

Side-by-side comparison

	CBD	Delta-9 THC	Delta-8 THC
Intoxicating?	No	Yes	Yes, typically milder than delta-9
Abundant in hemp?	Yes	Only in trace amounts (≤0.3% dry weight)	Produced via conversion from CBD, not in hemp flower at meaningful levels
Federally legal from hemp?	Yes, under 2018 Farm Bill	Yes, when derived from compliant hemp; capped per finished container from Nov 12, 2026 under H.R. 5371	State-dependent; regulatory status tightening
Age restriction	No federal minimum (some states set 21+)	21+ for hemp-derived product	21+ where sold
Drug-test risk	Low with isolate; present with full-spectrum	High	High (many tests don't distinguish delta-8 from delta-9)
Typical product framing	General daytime/evening wellness	Adult-use, relaxed social setting	"Milder THC" positioning

How they act in the body

Both CBD and THC interact with the endocannabinoid system (ECS) — a signaling network of receptors (primarily CB1 and CB2), endogenous messenger molecules and the enzymes that produce and break them down. THC binds directly and strongly to the CB1 receptor, which is heavily expressed in the brain and central nervous system; that direct binding is what produces the intoxicating experience. CBD does not meaningfully activate CB1 at the doses used in hemp products. Its effects on the ECS are more indirect — modulating how other compounds interact with the system rather than engaging the receptor directly.

This mechanism difference explains why CBD does not feel like THC. It also explains why many formulators combine the two in low-ratio products: small amounts of delta-9 THC alongside a larger CBD load tend to produce a rounder experience profile than either cannabinoid alone.

Legal status: the 2018 Farm Bill and H.R. 5371

Two pieces of federal policy govern modern hemp products in the United States.

2018 Farm Bill

The 2018 Farm Bill removed hemp — defined as cannabis sativa containing no more than 0.3% delta-9 THC on a dry-weight basis — from the Controlled Substances Act. That created the legal opening for the modern hemp-derived CBD, CBG, CBN, delta-9 and delta-8 product categories. The 0.3% threshold is measured at the plant or biomass stage, which is why a finished gummy or tincture can legally contain a small amount of delta-9 THC as long as the source hemp was compliant.

H.R. 5371 (effective November 12, 2026)

H.R. 5371 layers a finished-container ceiling on top of the Farm Bill: 0.4 mg of total THC per finished container for ingestible hemp products. "Total THC" here includes delta-9, delta-8 and the THCA that would convert to delta-9 on decarboxylation. The rule closes a loophole where a product could be labeled compliant at the plant stage but carry a meaningful THC dose at the consumer stage. Steve's Goods has been formulating to container-level totals for years, so the November 12 transition is a labeling refresh here, not a reformulation project.

Why products often combine them

Most compliant hemp ingestibles on the market pair CBD and a small dose of delta-9 THC. Two reasons:

1. Experience profile. Users commonly describe a low-dose CBD + THC ratio as more settled and consistent than either alone. What people are responding to is the combination — not CBD by itself and not a microdose of THC by itself.
2. Legal bandwidth. The Farm Bill and H.R. 5371 together define a narrow legal ceiling for THC in ingestibles. Formulating within that ceiling, alongside a larger CBD load, is how a modern hemp gummy is built.

For a deeper comparison of the hemp-derived THC categories, see our Delta 8 vs Delta 9 Guide. For the guide-format version of this comparison, see CBD vs THC Guide.

How to read a modern hemp label

1. Find the batch number. It should be on-pack. Look it up on Lab Reports and pull the batch-matched COA.
2. Read the total-THC line. Post-H.R. 5371 COAs report total THC at the finished-container level. That number should be at or below 0.4 mg for ingestibles.
3. Check the CBD potency line. Milligrams per unit and per container should both be printed on the label; the COA should confirm both.
4. Confirm third-party testing. The COA header should name an ISO/IEC 17025-accredited lab, not an in-house testing arm.

Frequently asked questions

Can CBD get me high?
No. CBD is not intoxicating at any realistic dose.

Can a legal hemp product contain THC?
Yes. Hemp products can legally contain small amounts of delta-9 THC. From November 12, 2026, ingestibles are capped at 0.4 mg total THC per finished container under H.R. 5371.

Will a full-spectrum CBD product fail a drug test?
It can. Full-spectrum means trace THC is present by design. If drug-test safety is critical, use a CBD isolate product with a COA that confirms non-detect THC.

Is delta-8 THC the same as delta-9 THC?
No. They are structural isomers — similar but not identical. Delta-8 is typically described as milder. See our Delta 8 vs Delta 9 Guide.

Is CBD age-restricted?
Federally, no. Some states set a 21+ minimum for hemp products generally. Products that contain any hemp-derived THC are 21+ regardless of state.

What is "total THC" on a COA?
It is the sum of delta-9 THC plus the amount of THCA that would convert to delta-9 on decarboxylation, sometimes plus delta-8 where present. It is the correct number to check against the H.R. 5371 ceiling.

Related reading

• CBD vs THC Guide
• Delta 8 vs Delta 9 Guide
• What is the Endocannabinoid System?

---

2026 Compliance Update — H.R. 5371 and Total-THC Math

One change worth flagging for anyone re-reading this guide in 2026: the federal hemp baseline is no longer just "0.3% delta-9 THC by dry weight." H.R. 5371 introduces a finished-product test for edibles: 0.4 milligrams of total-THC per finished container, calculated post-decarboxylation. Total-THC means delta-9 plus the delta-9 equivalent of any residual THCA, calculated as THCA × 0.877 + delta-9.

The practical consequence is that some products that comfortably passed the 2018 Farm Bill's percentage-by-dry-weight test no longer pass the 2026 finished-container math. This is most visible on high-cannabinoid edibles where THCA was technically below 0.3% by weight but the total-THC per package, after decarboxylation, exceeded 0.4 mg. The takeaway for consumers: the metric on a 2026-compliant COA is milligrams of total-THC per container, not a percentage.

Why CBD and THC Behave Differently in the Body

Both CBD and THC interact with the endocannabinoid system, but they do so through different mechanisms. THC binds directly to CB1 receptors concentrated in the central nervous system, which is why high-THC products produce intoxicating effects. CBD's relationship with CB1 is much weaker and more modulatory — it occupies a different binding site and influences receptor activity indirectly. This is the structural reason CBD is non-intoxicating at typical hemp-product doses.

The two cannabinoids also interact with each other. In a full-spectrum product, the small amount of legal THC plus the wider cannabinoid and terpene profile produce what is often called the "entourage" effect — the sum of the plant compounds behaving differently together than any one of them does in isolation. This is why full-spectrum and broad-spectrum and isolate products are not interchangeable even when their CBD-by-mg numbers are identical.

Legal Status by Product Type, 2026

• Hemp-derived CBD products. Federally legal under the 2018 Farm Bill, with state-by-state additional regulation. H.R. 5371 adds the 0.4 mg total-THC per finished container cap on edibles starting November 12, 2026.
• Hemp-derived delta-8 / delta-9 / delta-10. A moving target. Some states permit hemp-derived intoxicating cannabinoids; others have banned them outright. Always check current state law.
• Marijuana-derived THC products. Legal only in states with medical or adult-use cannabis programs, and only when purchased through licensed in-state dispensaries. Federally still Schedule I.

A Practical Decision Tree

If you are deciding between a CBD product and a THC product in 2026, the questions that actually matter are:

1. Are you subject to drug testing? If yes, full-spectrum products are higher risk; isolate-based products are lower risk. No CBD product is zero-risk for an individual.
2. Do you want intoxicating effects? If no, CBD or low-dose full-spectrum. If yes, the legal pathway depends on your state.
3. Is regulatory clarity a hard requirement (medical context, professional licensing, etc.)? Hemp-derived CBD with current, batch-specific COAs is the more defensible category.

Explore current formats: Full Spectrum CBD Gummies, CBD Isolate Softgels, or read the long-form CBD vs THC Guide.

Last updated: April 27, 2026